A detailed history of Petrus Trust Company, Lta transactions in Haemonetics Corp stock. As of the latest transaction made, Petrus Trust Company, Lta holds 6,416 shares of HAE stock, worth $582,252. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,416
Holding current value
$582,252
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $464,839 - $587,577
6,416 New
6,416 $515,000
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $201,304 - $249,016
-2,661 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $226,078 - $316,419
2,661 New
2,661 $238,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.66B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.